Antisense Oligonucleic Acid Patent - Osaka University EP3587576A1
Summary
The European Patent Office granted patent EP3587576A1 to Osaka University covering antisense oligonucleic acid compositions. The patent names inventors Obika, Satoshi; Waki, Reiko; Inoue, Takao; Yoshida, Tokuyuki; Morihiro, Kunihiko; Kasahara, Yuya; and Mikami, Atsushi. The patent is classified under IPC codes C12N 15/113, A61K 31/7115, A61K 31/712, and A61P 43/00, indicating pharmaceutical and therapeutic applications. Protection extends to designated contracting states including Germany, France, the United Kingdom, and other EU member states.
What changed
The European Patent Office published EP3587576A1, a patent application for antisense oligonucleic acid technology filed by Osaka University. The patent covers compositions and methods related to therapeutic oligonucleotides, with IPC classifications indicating pharmaceutical applications including A61K 31/7115 and A61K 31/712.
For pharmaceutical and biotechnology companies developing oligonucleotide-based therapeutics, this patent establishes intellectual property protection in European markets. Entities should review this patent when designing clinical programs or seeking European market authorization for similar antisense technologies to assess potential licensing requirements or freedom-to-operate considerations.
What to do next
- Monitor for updates
Archived snapshot
Apr 15, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
ANTISENSE OLIGONUCLEIC ACID
Publication EP3587576A1 Kind: A1 Apr 08, 2026
Applicants
Osaka University
Inventors
OBIKA, Satoshi, WAKI, Reiko, INOUE, Takao, YOSHIDA, Tokuyuki, MORIHIRO, Kunihiko, KASAHARA, Yuya, MIKAMI, Atsushi
IPC Classifications
C12N 15/113 20100101AFI20201127BHEP A61K 31/7115 20060101ALI20201127BHEP A61K 31/712 20060101ALI20201127BHEP A61P 43/00 20060101ALI20201127BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.